Niva Bupa Health Insurance Company Stock Screener | Share Price & Fundamental Analysis
NIVABUPA
General Insurance
Screen Niva Bupa Health Insurance Company share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹74.97
▼
-0.19 (-0.25%)
Share Price BSE
₹74.97
▼
-0.19 (-0.25%)
Market Cap
₹13,868.11 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
3.66
EPS (TTM)
₹1.22
Dividend Yield
-
Debt to Equity
0.42
52W High
₹92.35
52W Low
₹70.84
Operating Margin
-10.00%
Profit Margin
1.58%
Revenue (TTM)
₹5,886.00
EBITDA
₹93.00
Net Income
₹93.00
Total Assets
₹3,308.00
Total Equity
₹3,776.00
Niva Bupa Health Insurance Company Share Price History - Stock Screener Chart
Screen NIVABUPA historical share price movements with interactive charts. Analyze price trends and patterns.
Niva Bupa Health Insurance Company Company Profile - Fundamental Screener
Screen Niva Bupa Health Insurance Company company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NIVABUPA shares.
Sector
Insurance
Industry
General Insurance
Sub-Sector
General Insurance
Segment
E
ISIN
INE995S01015
Niva Bupa Health Insurance Company Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen NIVABUPA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 3,308 | 2,301 | 1,078 | 1,782 |
| Current Assets | 1,510 | 675 | 455 | 287 |
| Fixed Assets | 66 | 58 | 52 | 49 |
| Liabilities | ||||
| Total Liabilities | 3,308 | 2,301 | 1,078 | 1,782 |
| Current Liabilities | -469 | -682 | 250 | 250 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 3,776 | 2,983 | 828 | 1,532 |
| Share Capital | 1,827 | 1,700 | 1,511 | 1,409 |
| Reserves & Surplus | 1,950 | 1,282 | -680 | 125 |
Niva Bupa Health Insurance Company Income Statement Screener - Profit & Revenue Analysis
Intrinsic ValueScreen NIVABUPA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|
| Revenue | 5,886 | 5,530 | 4,336 | 3,223 | 2,159 |
| Expenses | 5,793 | 5,292 | 4,225 | 3,179 | 2,329 |
| EBITDA | 93 | 238 | 111 | 45 | -170 |
| Operating Profit % | -10.00% | 1.00% | -1.00% | -1.00% | -10.00% |
| Depreciation | 0 | 25 | 29 | 32 | 27 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 93 | 214 | 82 | 13 | -197 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 93 | 214 | 82 | 13 | -197 |
| EPS | 0.50 | 1.22 | 0.51 | 0.09 | -1.42 |
Niva Bupa Health Insurance Company Cash Flow Screener - Liquidity Fundamentals
Screen NIVABUPA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2017-March |
|---|---|---|---|---|---|---|
| Operating Activities | 1,654 | 813 | 593 | 338 | 257 | 8 |
| Investing Activities | -2,348 | -1,882 | -829 | -723 | -374 | -32 |
| Financing Activities | 771 | 1,110 | 280 | 374 | 281 | 28 |
| Net Cash Flow | 78 | 41 | 43 | -12 | 164 | 4 |
Screen NIVABUPA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Jun | 2024-Nov | 2024-Dec |
|---|---|---|---|---|---|---|
| Promoter Holding | 55.98% | 55.43% | 55.41% | 62.94% | 55.98% | 55.98% |
| FII Holding | 8.90% | 10.76% | 10.72% | 0.00% | 8.63% | 8.85% |
| DII Holding | 9.70% | 15.06% | 15.31% | 0.00% | 9.57% | 9.83% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 4.23% | 5.44% | 5.40% | 0.00% | 4.71% | 4.43% |
| Other Holding | 21.19% | 13.30% | 13.17% | 37.06% | 21.12% | 20.92% |
| Shareholder Count | 136,017 | 154,883 | 158,550 | 86 | 160,440 | 146,255 |
Niva Bupa Health Insurance Company Dividend Screener - Share Yield Analysis
Screen NIVABUPA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Niva Bupa Health Insurance Company Index Membership - Market Screener Classification
Screen NIVABUPA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Niva Bupa Health Insurance Company Market Events Screener - Corporate Actions
Screen NIVABUPA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-03 | 2025-11-03 | Quarterly Result Announcement | NA | 1.05% |
| 2025-08-26 | 2025-08-26 | Annual General Meeting | NA | -1.42% |
| 2025-07-31 | 2025-07-31 | Quarterly Result Announcement | NA | -1.92% |
| 2025-05-07 | 2025-05-07 | Quarterly Result Announcement | NA | -1.80% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | 6.33% |
| 2024-11-25 | 2024-11-25 | Quarterly Result Announcement | NA | -0.31% |
| 2022-03-31 | 2022-03-31 | Change Of Name | NA | - |
Niva Bupa Health Insurance Company Competitors Screener - Peer Comparison
Screen NIVABUPA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| ICICI Lombard General Insurance | 97,455 | 34.89 | 24,001 | 16.45% | 2,508 | 47.71 |
| GIC of India | 66,290 | 6.97 | 49,925 | 7.53% | 6,974 | 50.54 |
| Go Digit General Insurance | 32,035 | 62.60 | 9,696 | 12.54% | 425 | 49.83 |
| Star Health Insurance | 27,343 | 50.22 | 16,113 | 14.87% | 646 | 49.64 |
| The New India Assurance Company | 25,630 | 22.12 | 43,634 | 0.32% | 972 | 38.83 |
| Niva Bupa Health Insurance Company | 13,868 | 151.00 | 5,530 | 27.52% | 214 | 48.30 |
Niva Bupa Health Insurance Company Company Announcements - News Screener
Screen NIVABUPA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-04 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2026-01-04 | Closure of Trading Window | View |
| 2025-12-17 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-ESG Rating | View |
| 2025-12-05 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-11-13 | Disclosure Under SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-06 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-03 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-03 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-03 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-03 | Statement Of Deviation Or Variation For Quarter Ended September 2025 | View |
| 2025-11-03 | Board Meeting Outcome for Outcome Of The Board Meeting Held On November 03 2025 | View |
| 2025-11-03 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-10-31 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | View |
| 2025-10-28 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-10-28 | Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-10-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |